A review of pathological mechanisms that can explain the relationship between periodontitis and cardiovascular disease (CVD) is necessary to improve the management of both conditions. Metabolic syndrome is a combination of obesity, hypertension, impaired glucose tolerance or diabetes, hyperinsulinemia, and dyslipidemia. All these have been examined in recent years in terms of their relationship to periodontitis. Reviewed data indicate an association between some of them (body mass index, high-density lipoprotein-cholesterol [HDL-C], triglycerides, high blood pressure, among others) and periodontitis. Oxidative stress may act as a potential common link to explain relationships between each component of metabolic syndrome and periodontitis. Both conditions show increased serum levels of products derived from oxidative damage, with a pro-inflammatory state likely influencing each other bidirectionally. Adipocytokines might modulate the oxidant/anti-oxidant balance in this relationship.
Get full access to this article
View all access options for this article.
References
1.
Akalin FA, Baltacioglu E, Alver A, Karabulut E -2007-. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol34:558–565.
2.
Akalin FA, Isiksal E, Baltacioglu E, Renda N, Karabulut E -2008-. Superoxide dismutase activity in gingiva in type-2 diabetes mellitus patients with chronic periodontitis. Arch Oral Biol53:44–52.
3.
Al-Emadi A, Bissada N, Farah C, Siegel B, Al-Zaharani M -2006-. Systemic diseases among patients with and without alveolar bone loss. Quintessence Int37:761–765.
4.
Alberti KG, Zimmet PZ -1998-. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med15:539–553.
5.
Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al. -2007a-. Advanced glycation endproducts stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone40:345–353.
6.
Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT -2007b-. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Am J Physiol Cell Physiol292:C850–C856.
7.
American Diabetes Association -2005-. Diagnosis and classification of diabetes mellitus. Diabetes Care28 -Suppl 1-:37–42.
8.
Angeli F, Verdecchia P, Pellegrino C, Pellegrino RG, Pellegrino G, Prosciutti L, et al. -2003-. Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension41:488–492.
9.
Armitage GC -1999-. Development of a classification system for periodontal diseases and conditions. Ann Periodontol4:1–6.
10.
Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. -2002-. The European Group for the Study of Insulin Resistance -EGIR-. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Med28:364–376.
11.
Baltacioglu E, Akalin FA, Alver A, Balaban F, Unsal M, Karabulut E -2006-. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post-menopausal women with chronic periodontitis. J Clin Periodontol33:385–392.
12.
Baltacioglu E, Akalin FA, Alver A, Deger O, Karabulut E -2008-. Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis. Arch Oral Biol53:716–722.
13.
Barazzoni R, Bernardi A, Biasia F, Semolic A, Bosutti A, Mucci M, et al. -2007-. Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease: impact on plasma adiponectin concentration. Am J Physiol Regul Integr Comp Physiol293:R47–R54.
14.
Basta G, Schmidt AM, DeCaterina R -2004-. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res63:582–592.
15.
Battino M, Bullon P, Wilson M, Newman H -1999-. Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med10:458–476.
16.
Battino M, Ferreiro MS, Bompadre S, Leone L, Mosca F, Bullon P -2001-. Elevated hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome. J Periodontol72:1760–1766.
17.
Battino M, Ferreiro MS, Quiles JL, Bompadre S, Leone L, Bullon P -2003-. Alterations in the oxidation products, antioxidant markers, antioxidant capacity and lipid patterns in plasma of patients affected by Papillon-Lefèvre syndrome. Free Radic Res37:603–609.
18.
Baynes JW, Thorpe SR -2000-. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med28:1708–1716.
19.
Beltowski J, Wójcicka G, Marciniak A, Jamroz A -2004-. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci74:2987–3000.
20.
Borges PK, Gimeno SG, Tomita NE, Ferreira SR -2007-. Prevalence and characteristics associated with metabolic syndrome in Japanese-Brazilians with and without periodontal disease. Cad Saude Publica23: 657–668.
21.
Bouloumie A, Marumo T, Lafontan M, Busse R -1999-. Leptin induces oxidative stress in human endothelial cells. FASEB J13:1231–1238.
22.
Bozkurt FY, Yetkin Ay Z, Sütçü R, Delibaş N, Demirel R -2006-. Gingival crevicular fluid leptin levels in periodontitis patients with long-term and heavy smoking. J Periodontol77:634–640.
23.
Brock GR, Matthews JB, Butterworth CJ, Chapple ILC -2004-. Local and systemic antioxidant capacity in periodontitis and health. J Clin Periodontol31:515–521.
24.
Bruce CR, Carey AL, Hawley JA, Febbraio MA -2003-. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes52:2338–2345.
25.
Cameron AJ, Shaw JE, Zimmet PZ -2004-. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am33:351–375.
26.
Ceriello A -2000-. Oxidative stress and glycemic regulation. Metabolism49:27–29.
27.
Ceriello A, Motz E -2004-. Is oxidative stress the pathogenic mechanism underlying insulin resístance, diabetes and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol24:816–823.
28.
Chapple IL -1997-. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol24:287–296.
29.
Chapple IL, Matthews JB -2007-. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 200043:160–232.
30.
Chapple IL, Brock G, Eftimiadi C, Matthews JB -2002-. Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. Mol Pathol55:367–373.
31.
Chapple IL, Milward MR, Dietrich T -2007-. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr137:657–664.
32.
Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S -1998-. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol25:112–124.
33.
Collin HL, Sorsa T, Meurman JH, Niskanen L, Salo T, Rönkä H, et al. -2000-. Salivary matrix metalloproteinase -MMP-8- levels and gelatinase -MMP-9- activities in patients with type 2 diabetes mellitus. J Periodontal Res35:259–265.
34.
Cosentino F, Hishikawa K, Katusic ZS, Luscher TF -1997-. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation96:25–28.
35.
Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD -2003-. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol74:1007–1016.
36.
Cutler CW, Machen RL, Jotwani R, Iacopino AM -1999-. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol70:1313–1321.
37.
D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. -2008-. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrin Metab93:3989–3994.
38.
Dandona P, Aljada A, Mohanty P -2002-. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia45:924–930.
39.
Dandona P, Aljada A, Bandyopadhyay A -2004-. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol25:4–7.
40.
De Toni S, Piva E, Lapolla A, Fontana G, Fedele D, Plebani M -1997-. Respiratory burst of neutrophils in diabetic patients with periodontal disease. Ann NY Acad Sci832:363–367.
41.
Di Filippo C, Verza M, Coppola L, Rossi F, D’Amico M, Marfella R -2007-. Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree. Curr Diabetes Rev3:268–273.
El-Haschimi K, Pierroz DD, Hileman SM, Björbaek C, Flier JS -2000-. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest105:1827–1832.
44.
Engström S, Gahnberg L, Högberg H, Svärdsudd K -2007-. Association between high blood pressure and deep periodontal pockets: a nested case-referent study. Ups J Med Sci112:95–103.
45.
Esterbauer H, Schaur RJ, Zollner H -1991-. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med11:81–128.
46.
Esterbauer H, Gebicki J, Puhl H, Jürgens G -1992-. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med13:341–390.
47.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM -2003-. Are oxidative stress activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes52:1–8.
48.
Fardi A, Papadimitriou D -2007-. Periodontal and atherosclerosis-induced diseases. Int Angiol26:197–205.
49.
Fontana G, Lapolla A, Sanzari M, Piva E, Mussap M, De Toni S, et al. -1999-. An immunological evaluation of type II diabetic patients with periodontal disease. J Diabetes Complications13:23–30.
50.
Ford PJ, Yamazaki K, Seymour GJ -2007-. Cardiovascular and oral disease interactions: what is the evidence? Prim Dent Care14:59–66.
51.
Fredriksson M, Gustafsson A, Bergström K, Asman B -1998-. Hyper-reactive peripheral neutrophils in adult periodontitis: generation of chemiluminescence and intracellular hydrogen peroxide after in vitro priming and FcgammaR-stimulation. J Clin Periodontol25:395–398.
52.
Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H, et al. -2008-. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Clin Periodontol43:556–562.
53.
Furukawa T, Wakai K, Yamanouchi K, Oshida Y, Miyao M, Watanabe T, et al. -2007-. Associations of periodontal damage and tooth loss with atherogenic factors among patients with type 2 diabetes mellitus. Intern Med46:1359–1364.
54.
Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P -2004-. Circulating mononuclear cells in the obese are in a pro-inflammatory state. Circulation110:1564–1571.
55.
Gołebiewska M, Taraszkiewicz-Sulik K, Kuklińska A, Musiał WJ -2006-. Periodontal condition in patients with cardiovascular diseases. Adv Med Sci51-Suppl 1-:69–72.
56.
Gonçalves D, Correa FO, Khalil NM, de Faria Oliveira OM, Orrico SR -2008-. The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: a case-control pilot study. J Clin Periodontol35:799–806.
57.
Graves DT, Liu R, Oates TW -2007-. Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 200045:128–137.
58.
Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. -1997-. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol68:713–719.
59.
Grundy SM -2006-. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr83:1248–1251.
60.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant D -2004-. Definition of metabolic syndrome: report of the National, Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation109:433–438.
61.
Gustafsson A, Asman B -1996-. Increased release of free oxygen radicals from peripheral neutrophils in adult periodontitis after Fcgamma-receptor stimulation. J Clin Periodontol23:38–44.
62.
Gustafsson A, Asman B, Bergström K -1997-. Priming response to inflammatory mediators in hyperreactive peripheral neutrophils from adult periodontitis. Oral Dis3:167–171.
63.
Guzik TJ, Mangalat D, Korbut R -2006-. Adipocytokines—novel link between inflammation and vascular function? J Physiol Pharmacol57:505–528.
64.
Halliwell B -1991-. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med91:14–22.
65.
Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, et al. -2004-. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab89:4963–4971.
66.
Hattori S, Hattori Y, Kasai K -2005-. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism54:482–487.
67.
Herring ME, Shah SK -2006-. Periodontal disease and control of diabetes mellitus. J Am Osteopath Assoc106:416–421.
68.
Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T, et al. -2008-. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension51:446–453.
69.
Holmlund A, Holm G, Lind L -2006-. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J Periodontol77:1173–1178.
70.
Hotamisligil GS -2006-. Inflammation and metabolic disorders. Nature444:860–867.
Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. -2001-. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol72:774–778.
73.
Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, et al. -2003-. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol74:1231–1236.
74.
Janssen-Heininger YMW, Poynter ME, Baeuerle PA -2000-. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med28:1317–1327.
75.
Jenkins AJ, Best JD, Klein RL, Lyons TJ -2004-. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab Res Rev20:349–368.
76.
Johnson RB, Serio FG -2001-. Leptin within healthy and diseased human gingiva. J Periodontol72:1254–1257.
77.
Joshipura KJ, Wand HC, Merchant AT, Rimm EB -2004-. Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res83:151–155.
78.
Juge-Aubry CE, Henrichot E, Meier CA -2005-. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab19:547–566.
79.
Kahn R -2007-. Metabolic syndrome: is it a syndrome? Does it matter? Circulation115:1806–1811.
80.
Kahn R -2008-. Metabolic syndrome: what is the clinical usefulness? Lancet371:1891–1893.
81.
Kahn R, Buse J, Ferrandini E, Stern M -2005-. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care28:2289–2304.
82.
Karthikeyan BV, Pradeep AR -2007a-. Leptin levels in gingival crevicular fluid in periodontal health and disease. J Periodontal Res42:300–304.
83.
Karthikeyan BV, Pradeep AR -2007b-. Gingival crevicular fluid and serum leptin: their relationship to periodontal health and disease. J Clin Periodontol34:467–472.
84.
Katsuki A, Suematsu M, Gabazza EC, Murashima S, Nakatani K, Togashi K, et al. -2006-. Increased oxidative stress is asociated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract73:310–314.
85.
Katz J, Chaushu G, Sharabi Y -2001-. On the association between hyper-cholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol28:865–868.
86.
Katz J, Flugelman MY, Goldberg A, Heft M -2002-. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol73:494–500.
87.
Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW -2005-. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol32:40–44.
88.
Khader YS, Rice JC, Lefante JJ -2003-. Factors associated with periodontal diseases in a dental teaching clinic population in northern Jordan. J Periodontol74:1610–1617.
89.
Koerner A, Kratzsch J, Kiess W -2005-. Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab19:525–546.
90.
Konopka T, Król K, Kopec W, Gerber H -2007-. Total antioxidant status and 8-hydroxy-2′-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients. Arch Immunol Ther Exp55:417–422.
91.
Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al. -2005-. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol25:2587–2593.
92.
Kuo LC, Polson AM, Kang T -2008-. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health122:417–433.
93.
Leite CL, Redins CA, Vasquez EC, Meyrelles SS -2005-. Experimental-induced periodontitis is exacerbated in spontaneously hypertensive rats. Clin Exp Hypertens27:523–531.
94.
Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. -2006-. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res85:510–514.
95.
Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T -2000-. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol27:537–541.
96.
Lösche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF -2005-. Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol32:640–644.
97.
Machado AC, Quirino MR, Nascimento LF -2005-. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz Oral Res19:284–289.
98.
Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL -2001-. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes50:404–410.
99.
Maingrette F, Renier G -2003-. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes52:2121–2128.
100.
Margetic S, Gazzola C, Pegg GG, Hill RA -2002-. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord26:1407–1433.
101.
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I -2004-. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol24:29–33.
102.
Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, et al. -2008-. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism57:1071–1077.
103.
Matthews JB, Wright HJ, Ling-Mountford N, Cooper PR, Chapple ILC -2007a-. Neutrophil hyper-responsiveness in periodontitis. J Dent Res86:718–722.
104.
Matthews JB, Wright HJ, Roberts A, Cooper PR, Chapple ILC -2007b-. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin Exp Immunol147:255–264.
Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C -2004-. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol31:25–29.
107.
Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T -2004-. Relationship between blood triglyceride levels and periodontal status. Community Dent Health21:32–36.
108.
Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N -2005-. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism54:194–199.
109.
Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A -2007-. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol34:835–843.
110.
NCEP -2001-. Executive summary of the third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults -Adult Treatment Panel III-. J Am Med Assoc285:2486–2497.
Nibali L, D’Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS -2007-. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol34:931–937.
113.
Nichols GA, Hillier TA, Brown JB -2007-. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care30:228–233.
114.
Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS -2004-. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation109:42–46.
115.
Nishimura F, Taniguchi A, Yamaguchi-Morimoto M, Soga Y, Iwamoto Y, Kokeguchi S, et al. -2006-. Periodontal infection and dyslipidemia in type 2 diabetics: association with increased HMG-CoA reductase expression. Horm Metab Res38:530–535.
116.
Nishimura F, Iwamoto Y, Soga Y -2007-. The periodontal host response with diabetes. Periodontol 200043:245–253.
117.
Njoroge FG, Monnier VM -1989-. The chemistry of the Maillard reaction under physiological conditions: a review. Prog Clin Biol Res304:85–107.
118.
Noack B, Jachmann I, Roscher S, Sieber L, Kopprasch S, Lück C, et al. -2000-. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol71:898–903.
119.
Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrtover MD, Aykac Y, et al. -2007-. Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J100:686–691.
120.
Palmer RM, Wilson RF, Hasan AS, Scott DA -2005-. Mechanisms of action of environmental factors—tobacco smoking. J Clin Periodontol32-Suppl 6-:180–195.
121.
Panjamurthy K, Manoharan S, Ramachandran CR -2005-. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett10:255–264.
122.
Paolisso G, Giugliano D -1996-. Oxidative stress and insulin action. Is there a relationship? Diabetologia39:357–363.
123.
Paquette DW, Brodala N, Nichols TC -2007-. Cardiovascular disease, inflammation, and periodontal infection. Periodontol 200044:113–126.
124.
Perlstein MI, Bissada NF -1977-. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol43:707–719.
125.
Pischon N, Heng N, Bernimoulin JP, Kleber BM, Willich SN, Pischon T -2007-. Obesity, inflammation and periodontal disease. J Dent Res86:400–409.
126.
Pischon N, Pischon T, Kröger J, Gülmez E, Kleber BM, Bernimoulin JP, et al. -2008-. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol79:979–986.
127.
Pischon T, Hu FB, Rexrode KM, Girman CJ, Manson JE, Rimm EB -2008-. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis197:392–399.
128.
Preshaw PM, Foster N, Taylor JJ -2007-. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 200045:138–157.
129.
Reaven GM -1988-. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes37:1595–1607.
130.
Reaven GM -2005-. The metabolic syndrome: requiescat in pace. Clin Chem51:931–938.
131.
Reaven GM -2006-. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr83:1237– 1247; erratum in Am J Clin Nutr 84:1253, 2006.
132.
Rosen ED, Spiegelman BM -2006-. Adipocytes as regulators of energy balance and glucose homeostasis. Nature444:847–853.
133.
Saito T, Shimazaki Y -2007-. Metabolic disorders related to obesity and periodontal disease. Periodontol 200043:254–266.
134.
Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T -2003-. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol74:1741–1746.
135.
Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, et al. -2008-. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res87:319–322.
136.
Salcedo-Rocha AL, Sánchez-Mar M, López-Pérez ML, Preciado-Soltero HT, Figueroa-Suárez PA, Narváez-Aguirre VA, et al. -2006-. Oral signs in patients with type-2 diabetes, hypertension and obesity. Rev Med Inst Mex Seguro Soc44:203–210 [article in Spanish].
137.
Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, et al. -1996-. Advanced glycation endproducts -AGEs- induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res31:508–515.
138.
Semenkovich CF -2006-. Insulin resistance and atherosclerosis. J Clin Invest116:1813–1822.
139.
Sharma P, Mishra S, Ajmera P, Mathur S -2005-. Oxidative stress in metabolic syndrome. Indian J Clin Biochem20:145–149.
140.
Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y -2007-. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res86:271–275.
141.
Sjogren P, Basu S, Rosell M, Silveira A, De Faire U, Vessby B, et al. -2005-. Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol25:2580–2586.
142.
Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N, Lagarde M, et al. -2005-. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med38:882–889.
143.
Sonoki K, Nakashima S, Takata Y, Naito T, Fujisawa K, Ootsubo T, et al. -2006-. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients. J Periodontol77:1907–1913.
144.
Spiteller G -1998-. Linoleic acid peroxidation—the dominant lipid peroxidation process in low density lipoprotein—and its relationship to chronic diseases. Chem Phys Lipids95:105–162.
145.
Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, et al. -2003-. Adiponectin and protection against type 2 diabetes mellitus. Lancet361:226–228; erratum in Lancet 361:1060, 2003.
146.
Stewart JE, Wager KA, Friedlander AH, Zadeh HH -2001-. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol28:306–310.
147.
Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, et al. -2003-. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev4:259–266.
148.
Takeda M, Ojima M, Yoshioka H, Inaba H, Kogo M, Shizukuishi S, et al. -2006-. Relation of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetic patients. J Periodontol77:15–20.
149.
Tilg H, Moschen AR -2008-. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med14:222–231.
150.
Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, et al. -2003-. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes52:2882–2887.
151.
Trujillo ME, Scherer PE -2005-. Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med257:167–175.
152.
Tsai C, Hayes C, Taylor GW -2002-. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol30:182–192.
153.
Türkoğlu O, Bariş N, Kütükçüler N, Senarslan O, Güneri S, Atilla G -2008-. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol79:332–340.
154.
Valentaviciene G, Paipaliene P, Nedzelskiene I, Zilinskas J, Anuseviciene OV -2006-. The relationship between blood serum lipids and periodontal condition. Stomatologija8:96–100.
155.
Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA -2006-. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity14:2127–2131.
156.
Wakai K, Kawamura T, Umemura O, Hara Y, Machida J, Anno T, et al. -1999-. Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol26:664–672.
157.
Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK -2004-. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol44:1819–1824.
158.
World Health Organization -1999-. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. http://www.diabetes.com.au/pdf/who_report.pdf. -Last accessed on 2008-11-19-
Wright E, Scism-Bacon JL, Glass LC -2006-. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycemia. Int J Clin Pract60:308–314.
161.
Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT -2000-. Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol151:273–282.
162.
Yamaguchi N, Kukita T, Li YJ, Martinez Argueta JG, Saito T, Hanazawa S, et al. -2007-. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans.FEMS Immunol Med Microbiol49:28–34.
163.
Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T -2004-. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab89:87–90.
164.
Yoon MS, Jankowski V, Montag S, Zidek W, Henning L, Schlüter H, et al. -2004-. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun323:377–381.
165.
Zilinskas J, Zekonis J, Zekonis G, Valantiejiene A, Periokaite R -2007-. The reduction of nitroblue tetrazolium by total blood in periodontitis patients and the aged. Stomatologija9:105–108.
